$57.65 +0.77 (%) Merck & Co Inc - NYSE

Apr. 20, 2015 | 03:40 PM

Partner Headlines

  1. Bristol, Merck Cancer Drugs Strut Their Stuff

    IBD | Apr. 20, 2015 | 11:29AM EST
  2. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  3. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 16:14PM EST
  4. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 10:44AM EST
  5. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD | Apr. 14, 2015 | 14:37PM EST
  6. UPDATE: Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone

    Benzinga | Apr. 14, 2015 | 13:30PM EST
  7. Robert Bruce's Top Growth Stocks

    GuruFocus | Apr. 13, 2015 | 21:36PM EST
  8. Fast Money Picks For March 2

    Benzinga | Mar. 1, 2015 | 18:54PM EST
  9. Heavy News Day For Several Biotech Stocks

    Benzinga | Feb. 25, 2015 | 15:34PM EST
  10. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  11. PRIMECAP Management's New Positions

    GuruFocus | Feb. 13, 2015 | 15:47PM EST
  12. Microsoft Does Largest Corporate Debt Sale Of Year

    IBD | Feb. 9, 2015 | 16:59PM EST
  13. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD | Feb. 9, 2015 | 16:53PM EST
  14. Gabelli's Q4 Picks Include Acquisition Targets

    GuruFocus | Feb. 6, 2015 | 10:44AM EST
  15. Fast Money Halftime Report Final Trade From February 5

    Benzinga | Feb. 6, 2015 | 06:45AM EST
  16. Gilead Sciences Falls 10% After More Than Doubling Drug Discounts For 2015

    GuruFocus | Feb. 5, 2015 | 11:35AM EST
  17. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  18. Merck hep C drug faces delays

    IBD | Feb. 4, 2015 | 19:29PM EST
  19. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  20. UPDATE: Merck Posts Upbeat Q4 Earnings, Sales Decline

    Benzinga | Feb. 4, 2015 | 08:03AM EST
  21. Earnings Scheduled For February 4, 2015

    Benzinga | Feb. 4, 2015 | 05:08AM EST
  22. Keep an Eye on These 10 Stocks for February 4, 2015

    Benzinga | Feb. 4, 2015 | 04:08AM EST
  23. Irving Kahn Adds to Stakes in Three Companies in Q4

    GuruFocus | Feb. 3, 2015 | 16:18PM EST
  24. What Investors Are Watching For In Regulus Therapeutics' Next Data Release

    Benzinga | Jan. 30, 2015 | 14:32PM EST
  25. Fast Money Halftime Report Final Trade From January 27

    Benzinga | Jan. 27, 2015 | 21:27PM EST
  26. White House Budget To Support Biotech Rally

    Benzinga | Jan. 27, 2015 | 16:00PM EST
  27. Putting Recent Layoff Reports in Economic Perspective

    FoxBusiness | Jan. 26, 2015 | 13:02PM EST
  28. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  29. The 5 Best Dow Stocks So Far In 2015

    Benzinga | Jan. 20, 2015 | 17:33PM EST
  30. World Economic Forum 2015 - What To Look Forward For

    GuruFocus | Jan. 18, 2015 | 07:40AM EST
  31. Barclays Issues 3 Upgrades, 1 Downgrade On Pharma Stocks

    Benzinga | Jan. 16, 2015 | 15:12PM EST
  32. Merck Takes A Step Forward In The World Of Medicine

    GuruFocus | Jan. 16, 2015 | 11:23AM EST
  33. Fast Money Halftime Report Final Trade From January 14

    Benzinga | Jan. 15, 2015 | 06:26AM EST
  34. Top Cybersecurity Stock Qualys Gets Support

    IBD | Jan. 13, 2015 | 17:42PM EST
  35. Stocks Rumble Ahead Despite Oil; Alaska Air, Celgene, Apple Jump

    IBD | Jan. 13, 2015 | 10:34AM EST
  36. Bristol-Myers Hits 14-Year High On Cancer Drug Trial

    IBD | Jan. 12, 2015 | 14:25PM EST
  37. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  38. Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014

    GuruFocus | Jan. 9, 2015 | 10:25AM EST
  39. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  40. Stock Indexes Gun For Best Pop In 3 Weeks; Monster Breaks Out

    IBD | Jan. 7, 2015 | 14:48PM EST
  41. Stocks Drop 1% In Rising Volume; Visa Falls 1%

    IBD | Jan. 5, 2015 | 10:33AM EST
  42. Ebola Drug Work Continues

    IBD | Dec. 26, 2014 | 18:22PM EST
  43. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  44. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  45. FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities

    Benzinga | Dec. 23, 2014 | 15:22PM EST
  46. Indexes Turn Mixed On Data; Celgene Dives

    IBD | Dec. 23, 2014 | 10:43AM EST
  47. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD | Dec. 22, 2014 | 10:34AM EST
  48. NewLink Genetics Surges 3% Following Ebola Contract News

    Benzinga | Dec. 22, 2014 | 09:32AM EST
  49. Tetraphase Jumps As 'Superbug' Drug Scores In Trial

    IBD | Dec. 18, 2014 | 11:54AM EST
  50. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus | Dec. 15, 2014 | 16:57PM EST
Trading Center